Skip to main content

Table 3 Comparison of clinicopathologic factors of early gastric cardiac with or without oesophageal invasion

From: Distinct clinicopathological differences between early gastric cardiac and non-cardiac carcinomas: a single-center retrospective study of 329 radical resection cases

Clinicopathologic factor

Oesophageal invasion

Total

P value

Without

With

Number

48

22 (1–10 mm, 4.16 ± 2.82 mm)

70

NS

Gender

    

 Male

37 (77.1)

13 (59.1)

50 (71.4)

NS

 Female

11 (22.9)

9 (40.9)

20 (28.6)

 

 M/F ratio

3.36

1.44

2.50

 

Age (year)

    

 ≤ 40

0 (0)

0

0

NS

 41–69

35 (72.9)

19 (86.4)

54 (77.1)

 

 ≥ 70

13 (27.1)

3 (13.6)

16 (22.9)

 

 Average (SD)

64.44 ± 7.57

63.14 ± 7.88

64.03 ± 7.63

NS

Origin

    

 Gastric

48 (100)

22 (100)

70 (100)

NS

 Oesophagus

0 (0)

0 (0)

0 (0)

 

Metaplasia

    

 Without

14 (29.2)

6 (27.3))

20 (28.6)

NS

 Columnar cell

23 (47.9)

11 (50.0)

34 (48.6)

 

 Pancreatic

10 (20.8)

3 (13.6)

13 (18.6)

 

 Goblet cell

1 (2.1)

2 (9.1)

3 (4.3)

 

Macroscopic feature

    

 I

3 (6.3)

2 (9.1)

5 (7.1)

NS

 IIa

2 (4.2)

0 (0)

2 (2.9)

 

 IIb

10 (20.8)

6 (27.3)

16 (22.9)

 

 IIc

17 (35.4)

6 (27.3)

23 (32.9)

 

 III

16 (33.3)

8 (36.4)

24 (34.3)

 

 I + IIa

5 (10.4)

2 (9.1)

7 (10.0)

NS

 IIb

10 (20.8)

6 (27.3)

16 (22.9)

 

 IIc + III

33 (68.8)31

14 (63.6)

47 (67.1)

 

Size (cm)

    

 ≤ 0.9

10 (20.8)

2 (9.1)

12 (17.1)

NS

 1–1.9

21 (43.8)

5 (22.7)

26 (37.1)

 

 2–2.9

12 (25.0)

8 (36.4)

20 (28.6)

 

 > 3

5 (10.4)

7 (31.8)

12 (17.1)

 

Invasion depth

    

 M2

7 (14.6)

2 (9.1)

9 (12.9))

NS

 M3

14 (29.2)

5 (22.7)

19 (27.1)

 

 SM1

7 (14.6)

3 (13.6)

10 (14.3)

 

 SM2

20 (41.7)

12 (54.5)

32 (45.7)

 

Histology type

    

 Tubular adenocarcinoma

32 (66.7)

8 (36.4)

40 (57.1)

< 0.05

 Papillary adenocarcinoma

7 (14.6)

6 (27.3)

13 (18.6)

 

 Micropapillary adenocarcinomaa

1 (2.1)

0 (0)

1 (1.4)

 

 Poorly cohesive carcinoma

1 (2.1)

1 (4.5)

2 (2.8)

 

 Mucinous carcinoma

1 (2.1)

0 (0)

1 (1.4)

 

 Mixed PCC and adenocarcinoma

3 (6.3)

3 (13.6)

6 (8.6)

 

 Mixed mucinous and tubular adenocarcinoma

1 (2.1)

2 (9.1)

3 (4.3)

 

 Neuroendocrine/medullary /adenosquamous/clear cell carcinoma

2 (4.2)

2 (9.1)

4 (5.7)

 

Differentiation

    

 Well

13 (27.1)

4 (18.2)

17 (24.3)

NS

 Moderate

28 (58.3)

14 (63.6)

42 (60.0)

 

 Poorly

7 (14.6)

4 (18.2)

11 (15.7)

 

Lymphovascular invasion

    

 Absence

42 (87.5)

17 (77.3)

59 (84.3)

NS

 Presence

6 (12.5)

5 (22.7)

11 (15.7)

 

Perineural invasion

    

 Absence

46 (95.8)

21 (95.5)

67 (95.7)

NS

 Presence

2 (4.2)

1 (4.5)

3 (4.3)

 

Lymph node metastasis

    

 Absence

43 (89.6)

20 (90.9)

63 (90.0)

NS

 Presence

5 (10.4))

2 (9.1)

7 (10.0)

 

 N1

4 (8.3)

1 (4.5)

5 (7.1)

 

 N2

1 (2.1)

0 (0)

1 (1.4)

 

 N3

0 (0.0)

1 (4.5)

1 (1.4)

 
  1. SD standard deviation, PCC poorly cohesive carcinoma, NS not significant